4/Excitingly, the FDA has recently taken a new look at old-school psychedelics, allowing research on psychedelic pharmaceuticals as “breakthrough therapies” such as MDMA for PTSD and psilocybin and a variant of ketamine for resistant depression.
4/Excitingly, the FDA has recently taken a new look at old-school psychedelics, allowing research on psychedelic pharmaceuticals as “breakthrough therapies” such as MDMA for PTSD and psilocybin and a variant of ketamine for resistant depression.